RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity

Alex B. Green(Beth Israel Deaconess Medical Center), James E. Kirby(Beth Israel Deaconess Medical Center), Zhemin Zhang(University Medical Center), Matthew P. Ware(Beth Israel Deaconess Medical Center), Lucius Chiaraviglio(Beth Israel Deaconess Medical Center), Edward Yu(University School), Richard L. Haspel(Beth Israel Deaconess Medical Center), Meng Cui, Willy A. Flegel(National Institutes of Health Clinical Center), Katelyn E. Zulauf(Beth Israel Deaconess Medical Center), Katherine A. Truelson(Beth Israel Deaconess Medical Center)

mSphere

February 28, 2023

Cited by 10

|PLoS ONE|2010|1k

|Blood|1999|336

|Blood|1999|331

|Blood|2000|319

|BMC Genetics|2001|310

Related Papers